Skip to content
  • Sunday, 26 July 2026
  • 3:37 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • The FDA’s Pursuit of "Radical Transparency" Sparks Debate on Policy Clarity
Pharmaceutical R&D

The FDA’s Pursuit of "Radical Transparency" Sparks Debate on Policy Clarity

Teuku Ryan Jun 29, 2026 0

The U.S. Food and Drug Administration’s (FDA) ambitious drive towards "radical transparency," particularly through the public release of Complete Response…

Read More
Data Science & Bioinformatics

Visual Debugging Tools for Machine Learning: Essential Strategies for Model Transparency and Performance.

Evan Lee Salim May 26, 2026 0

The intricate process of training a machine learning model often presents a paradox: the satisfaction of observing declining loss curves…

Read More
Cornell University Engineers Develop Microscale Wireless Neural Implant Capable of Long-Term Brain Activity Monitoring and Data TransmissionStanford Researchers Discover Protein Inhibitor That Reverses Cartilage Loss and Prevents OsteoarthritisMemory Decline After Menopause Linked to Loss of Estrogen Production in Brain Tissue, Shedding Light on Alzheimer’s Risk in WomenAbacus AI Emerges as a Comprehensive Solution Addressing AI Tool Sprawl and Enhancing Enterprise Workflow Automation
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ